TDP1 and cancer: Together with topoisomerase inhibitors, NSC120686 has been used as a pharmacophoric model to suppress the TDP1 activity as part of a synergistic treatment for cancer therapies (Perego et al., 2012) whereas, in plants, dose-dependent genotoxicity was evidenced (Macovei et al., 2018a).